Tag Archives: AUST L

APHC 2018 Contested Policy: Complementary Medicines and Advertising Reform

Abstract: PHAA Workshop – Complementary medicine and advertising reform Chair: Ken Harvey Speakers: John Skerritt – Overview of MMD recommendations Alanna Rottler – Pre-approval of certain advertisements to cease Jon Wardle – Permitted indications to replace ARTG ‘free text’ Alanna … Continue reading

Posted in Complementary medicine, Education, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Complementary Medicine Regulation Reform Suggestions

My submission to the TGA Working Group on Complementary Medicine Regulation Reform as a representative of:     Problem It is alleged that some sponsors are not aware of the regulatory issues concerning complementary medicines including the Therapeutic Goods Advertising … Continue reading

Posted in Complementary medicine | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment